Kelly, Aaron S.
Article History
Accepted: 24 May 2023
First Online: 19 June 2023
Competing interests
: A.S.K. engages in unpaid consulting and educational activities for Novo Nordisk, Vivus, Eli Lilly, and Boehringer Ingelheim and receives donated drugs/placebo from Vivus and donated drugs from Novo Nordisk for National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)-funded clinical trials.